New RNA stem cell editing reduces unintended genetic complications

Date: October 3, 2016

Source: Sbarro Health Research Organization (SHRO)

Summary:  An international collaboration of government, university, and industry resources showed the promise of using RNA as a safe way to both make and modify induced Pluripotent Stem Cells (iPSCs) from patient cells for clinical applications in regenerative medicine, tissue engineering, and personalized medicine.

For more info, see the ScienceDaily release.